Author: Statsenko, Yauhen; Al Zahmi, Fatmah; Habuza, Tetiana; Gorkom, Klaus Neidl-Van; Zaki, Nazar
Title: Prediction of COVID-19 severity using laboratory findings on admission: informative values, thresholds, ML model performance Cord-id: 90hymaz9 Document date: 2021_2_26
ID: 90hymaz9
Snippet: BACKGROUND: Despite the necessity, there is no reliable biomarker to predict disease severity and prognosis of patients with COVID-19. The currently published prediction models are not fully applicable to clinical use. OBJECTIVES: To identify predictive biomarkers of COVID-19 severity and to justify their threshold values for the stratification of the risk of deterioration that would require transferring to the intensive care unit (ICU). METHODS: The study cohort (560 subjects) included all cons
Document: BACKGROUND: Despite the necessity, there is no reliable biomarker to predict disease severity and prognosis of patients with COVID-19. The currently published prediction models are not fully applicable to clinical use. OBJECTIVES: To identify predictive biomarkers of COVID-19 severity and to justify their threshold values for the stratification of the risk of deterioration that would require transferring to the intensive care unit (ICU). METHODS: The study cohort (560 subjects) included all consecutive patients admitted to Dubai Mediclinic Parkview Hospital from February to May 2020 with COVID-19 confirmed by the PCR. The challenge of finding the cut-off thresholds was the unbalanced dataset (eg, the disproportion in the number of 72 patients admitted to ICU vs 488 non-severe cases). Therefore, we customised supervised machine learning (ML) algorithm in terms of threshold value used to predict worsening. RESULTS: With the default thresholds returned by the ML estimator, the performance of the models was low. It was improved by setting the cut-off level to the 25th percentile for lymphocyte count and the 75th percentile for other features. The study justified the following threshold values of the laboratory tests done on admission: lymphocyte count <2.59×10(9)/L, and the upper levels for total bilirubin 11.9 μmol/L, alanine aminotransferase 43 U/L, aspartate aminotransferase 32 U/L, D-dimer 0.7 mg/L, activated partial thromboplastin time (aPTT) 39.9 s, creatine kinase 247 U/L, C reactive protein (CRP) 14.3 mg/L, lactate dehydrogenase 246 U/L, troponin 0.037 ng/mL, ferritin 498 ng/mL and fibrinogen 446 mg/dL. CONCLUSION: The performance of the neural network trained with top valuable tests (aPTT, CRP and fibrinogen) is admissible (area under the curve (AUC) 0.86; 95% CI 0.486 to 0.884; p<0.001) and comparable with the model trained with all the tests (AUC 0.90; 95% CI 0.812 to 0.902; p<0.001). Free online tool at https://med-predict.com illustrates the study results.
Search related documents:
Co phrase search for related documents- absolute value and accurate prediction: 1
- absolute value and acute phase: 1
- absolute value and acute respiratory failure: 1
- absolute value and additional information: 1
- access disease and acute care hospital: 1
- access disease and acute phase: 1, 2, 3
- access disease and acute respiratory failure: 1
- accurate prediction and acute phase: 1
- accurate prediction and acute respiratory failure: 1
- accurate prediction and admission dimer: 1, 2
- acute care hospital and additional information: 1, 2
- acute care hospital and additional information provide: 1
- acute inflammation and additional information: 1
- acute inflammation and admission dimer: 1
- acute phase and additional information: 1
- acute phase and admission dimer: 1, 2
- acute respiratory failure and additional information: 1, 2
- acute respiratory failure and admission dimer: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date